Insider Trading & Ownership - ReShape Weightloss Inc. (RSLS)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for ReShape Weightloss Inc.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-06-15
Sale
2021-06-17
4:06 pm
ReShape Lifesciences Inc. RSLS STANKOVICH THOMAS
Chief Financial Officer
4,635 $3.05 $14,137 0
(Direct)
View
2020-12-02
Purchase
2020-12-04
6:47 pm
ReShape Lifesciences Inc. RSLS ARMISTICE CAPITAL LLC
Armistice Capital Master Fund Ltd.
Boyd Steven
10% Owner
6,400 $4.1581 $26,612 10,660,554
(Indirect
Direct)
View
2020-11-13
Purchase
2020-11-17
7:02 pm
ReShape Lifesciences Inc. RSLS ARMISTICE CAPITAL LLC
Armistice Capital Master Fund Ltd.
Boyd Steven
10% Owner
977 $4.2089 $4,112 10,647,754
(Indirect
Direct)
View
2020-11-10
Purchase
2020-11-12
6:23 pm
ReShape Lifesciences Inc. RSLS ARMISTICE CAPITAL LLC
Armistice Capital Master Fund Ltd.
Boyd Steven
10% Owner
2,400 $3.58 $8,592 10,645,800
(Indirect
Direct)
View
2020-11-02
Purchase
2020-11-04
8:12 pm
ReShape Lifesciences Inc. RSLS ARMISTICE CAPITAL LLC
Armistice Capital Master Fund Ltd.
Boyd Steven
10% Owner
3,100 $3.56 $11,036 10,641,000
(Indirect
Direct)
View
2020-09-23
Purchase
2020-09-25
4:57 pm
ReShape Lifesciences Inc. RSLS ARMISTICE CAPITAL LLC
Armistice Capital Master Fund Ltd.
Boyd Steven
10% Owner
2,000 $4.07 $8,140 10,634,800
(Indirect
Direct)
View
2020-09-18
Purchase
2020-09-22
5:49 pm
ReShape Lifesciences Inc. RSLS ARMISTICE CAPITAL LLC
Armistice Capital Master Fund Ltd.
Boyd Steven
10% Owner
3,300 $4.1348 $13,645 10,630,800
(Indirect
Direct)
View
2020-09-16
Purchase
2020-09-17
6:08 pm
ReShape Lifesciences Inc. RSLS STANKOVICH THOMAS
Chief Financial Officer
530 $3 $1,590 4,635
(Direct)
View
2020-09-16
Purchase
2020-09-16
8:43 pm
ReShape Lifesciences Inc. RSLS ARMISTICE CAPITAL LLC
Armistice Capital Master Fund Ltd.
Boyd Steven
10% Owner
100 $3.75 $375 25,924,200
(Indirect
Direct)
View
2020-08-18
Purchase
2020-08-20
6:58 pm
ReShape Lifesciences Inc. RSLS ARMISTICE CAPITAL LLC
Armistice Capital Master Fund Ltd.
Boyd Steven
10% Owner
9,998 $3.125 $31,244 10,624,000
(Indirect
Direct)
View
2020-08-19
Purchase
2020-08-20
4:18 pm
ReShape Lifesciences Inc. RSLS STANKOVICH THOMAS
Chief Financial Officer
4,105 $3 $12,315 4,105
(Direct)
View
2020-07-17
Purchase
2020-07-21
5:27 pm
ReShape Lifesciences Inc. RSLS ARMISTICE CAPITAL LLC
Armistice Capital Master Fund Ltd.
Boyd Steven
10% Owner
4,500 $3 $13,500 10,604,004
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2021-06-15
Other
2021-06-22
08:33 am
N/A
2024-11-12
ReShape Weightloss Inc. RSLS ARMISTICE CAPITAL LLC
Armistice Capital Master Fund Ltd.
Boyd Steven
10% Owner
17,980,277 $0 5,330,277
(Direct)
View
2020-09-14
Other
2020-09-16
8:43 pm
2020-09-14
2025-09-14
ReShape Lifesciences Inc. RSLS ARMISTICE CAPITAL LLC
Armistice Capital Master Fund Ltd.
Boyd Steven
10% Owner
1,200,000 $0 25,924,200
(Direct)
View